Congress Summaries

ASH_Report_Jan15_21.pdf

Updates from the ASH 2020 annual meeting: practice-changing studies in CLL

Highlights from ASCO 2020: updates on the treatment of CLL

Updates from the ASH 2019 annual meeting: practice-changing studies in treatment-naïve CLL

Updates from the 2019 ASCO and EHA annual meetings: a Canadian perspective on high-risk cytogenetics in MM

Updates from the 2017 ASH annual meeting: practice-changing studies in relapsed and refractory MCL

Tel. 416-434-8923